Skip to Main Content

Paper Details

A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer.
Clin Genitourin Cancer
21
2020
Author NameAffiliation
Michael J MorrisMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Howard I ScherMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Dana E RathkopfMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College
  • 1 - 3

Datasets

Release 1.2